Company Filing History:
Years Active: 1995-2002
Title: The Innovative Contributions of Christophe P Gerald
Introduction
Christophe P Gerald is a notable inventor based in Ridgewood, NJ (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of receptor research. With a total of 10 patents to his name, Gerald's work has advanced our understanding of various receptors and their applications in medicine.
Latest Patents
Gerald's latest patents include a groundbreaking invention titled "Method of obtaining compositions comprising Y2 specific compounds." This invention provides isolated nucleic acid molecules encoding Y2 receptors, an isolated, purified Y2 receptor protein, and vectors comprising these isolated nucleic acid molecules. Additionally, it encompasses mammalian, insect, bacterial, and yeast cells that contain such vectors, as well as antibodies directed to the Y2 receptors. The invention also includes nucleic acid probes useful for detecting nucleic acid encoding Y2 receptors, antisense oligonucleotides complementary to unique sequences of a nucleic acid molecule encoding a Y2 receptor, and pharmaceutical compounds related to the Y2 receptors. Furthermore, it describes nonhuman transgenic animals that express nucleic acid encoding a normal or mutant Y2 receptor. The methods provided in this patent are essential for determining ligand binding, detecting expression, drug screening, and treatment methods involving Y2 receptors.
Another significant patent focuses on the uses of the 5-HT4 receptor. This invention outlines a process for identifying a chemical compound that specifically binds to a rat or human 5-HT4 receptor. It also details competitive binding processes for identifying such compounds and methods for determining whether a chemical compound activates or inhibits the activation of the 5-HT4 receptor.
Career Highlights
Christophe P Gerald is currently associated with Synaptic Pharmaceutical Corporation, where he continues to innovate and contribute to the field of receptor research. His work has been instrumental in developing new therapeutic approaches that target specific receptors, thereby enhancing treatment options for various medical conditions.
Collaborations
Throughout his career, Gerald has collaborated with esteemed colleagues, including Richard L Weinshank and Theresa A Branchek. These collaborations have further enriched his research and expanded the impact of his inventions.
Conclusion
Christophe P Gerald's contributions to the field of receptor research are invaluable. His innovative patents and ongoing work at Synaptic Pharmaceutical Corporation continue to pave the way for advancements in pharmaceutical